BDX vs PATH
Becton Dickinson and Company (BDX) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Becton Dickinson and Company (BDX) is a medical instruments & supplies company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported BDX revenue for 2025-09-30 was $21.84B. Net income was $1.68B. Revenue was up 8.2% from 2024-09-30 to 2025-09-30. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
BDX currently screens at market cap $50.30B and trailing P/E 33.9. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the BDX and PATH stock pages for the full models.
Not investment advice.